NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

Aemetis Reports Third Quarter 2026 Financial Results

2h ago🟢 Genuine Positive Shift
Share𝕏inf

Aemetis posts a $5.2 million profit on strong tax credits and operational gains.

What the company is saying

Aemetis, Inc. reports a sharp turnaround in profitability for Q3 2026, highlighting $88.2 million in revenue, which includes $24.7 million from Section 45Z production tax credits. CFO Todd Waltz attributes the results to strong execution in the California Ethanol and Dairy Renewable Natural Gas segments, and notes the September 8 update to the 45ZCF-GREET model, which raised the Section 45Z credit for dairy RNG from about $15 to $62 per MMBtu. CEO Eric McAfee emphasizes ongoing growth in Aemetis Biogas production and a focus on improving cash flow in the California Ethanol segment through expanded corn oil production and the near-completion of a mechanical vapor recompression system. The company frames its narrative around operational progress, regulatory tailwinds, and capital investment, while also mentioning multi-track financing efforts and a potential IPO for its India subsidiary. The tone is confident, with management directly linking profitability improvements to both policy changes and operational execution.

What the data suggests

Q3 2026 revenues rose 49% year-over-year to $88.2 million, with Section 45Z tax credits contributing $24.7 million, including an $11.0 million cumulative true-up for prior quarters. Dairy RNG sales increased 39% to 158,200 MMBtu, and ethanol volumes rose 6% to 15.6 million gallons, with average ethanol prices up 10% to $2.34 per gallon. Biodiesel sales fell to $7.3 million from $13.9 million, reflecting resumed shipments to India Oil Marketing Companies. Gross profit swung from a $58,000 loss to a $29.5 million profit, and operating income improved by $29.4 million to $20.9 million. Net income was $5.2 million, or $0.07 per share, compared to a $23.7 million loss a year earlier. Adjusted EBITDA reached $24.8 million, up from negative $5.0 million. Cash at quarter-end was $3.4 million. Capital investments totaled $20.2 million for the quarter and $35.3 million year-to-date. For the first nine months, revenues were $205.5 million, gross profit $45.7 million, and net loss narrowed to $25.9 million from $71.7 million. The improvement is directly tied to increased production, higher prices, and the expanded value of tax credits following regulatory changes.

Analysis

The announcement is highly factual and supported by detailed, realised financial and operational data. Key profitability metrics (gross profit, operating income, net income, adjusted EBITDA) are disclosed alongside revenue and segment-level operational figures, satisfying the requirements for a strong_positive signal. While there are some forward-looking statements regarding financing plans and project completion, these are clearly separated from the realised results and do not dominate the narrative. The majority of the release focuses on actual performance improvements, including a swing to net income and significant EBITDA growth. Capital investments are disclosed, but the benefits from these outlays are already being realised or are near completion, with no evidence of excessive narrative inflation or overstatement. The tone is positive but proportionate to the underlying results.

Risk flags

  • ●Aemetis remains highly dependent on Section 45Z tax credits, which contributed $24.7 million to Q3 revenue and $37.3 million year-to-date. Any future policy change or expiration could materially impact profitability.
  • ●Cash reserves are low at $3.4 million at quarter-end, despite positive operating cash flow, indicating limited liquidity buffer relative to ongoing capital commitments and interest expense of $15.8 million for the quarter.
  • ●The company is pursuing multiple financing initiatives, including long-term refinancing and a potential IPO for its India subsidiary, but none are finalized. Delays or failures in securing these funds could constrain growth or stress the balance sheet.
  • ●Capital expenditures remain high, with $20.2 million invested in Q3 and $35.3 million year-to-date, increasing execution risk if project returns or regulatory incentives do not materialize as expected.
  • ●Biodiesel sales remain volatile, dropping from $13.9 million to $7.3 million year-over-year, and are subject to tender allocations and demand from India Oil Marketing Companies, adding revenue uncertainty.

Bottom line

Aemetis has delivered a clear operational and financial turnaround, swinging to a $5.2 million net profit in Q3 2026 on the back of higher production, improved pricing, and a substantial boost from Section 45Z tax credits. The company’s results are now heavily reliant on these regulatory incentives, which accounted for over a quarter of quarterly revenue, making future earnings sensitive to policy changes. Liquidity remains tight, with just $3.4 million in cash, and ongoing capital projects and interest costs continue to pressure the balance sheet. While operational execution and regulatory tailwinds have driven near-term gains, the sustainability of these improvements depends on successful completion of capital projects, realization of planned financings, and continued policy support. Investors should focus on the durability of tax credits, progress on financing and the India IPO, and the company’s ability to convert capital investment into lasting cash flow. The key takeaway is that Aemetis’s profitability is real but fragile, hinging on both execution and external policy factors.

Announcement summary

(NASDAQ:AMTX) Aemetis, Inc. reported financial results for the three and nine months ended September 30, 2026. Revenues for the third quarter of 2026 were $88.2 million, including $24.7 million of Section 45Z production tax credits. The Dairy RNG segment sold 158,200 MMBtu during the third quarter, up 39% from 114,000 MMBtu in the prior year period. Ethanol gallons sold increased 6% to 15.6 million gallons, with the average ethanol selling price rising 10% from $2.13 to $2.34 per gallon. Biodiesel sales were $7.3 million in Q3 2026, compared to $13.9 million in Q3 2025, as shipments to India Oil Marketing Companies resumed under tender allocations awarded in late July 2026. Section 45Z tax credit income recognized as revenue was $24.7 million, comprised of $20.1 million for Dairy RNG and $4.6 million for the California Ethanol segment, including an $11.0 million cumulative true-up for RNG dispensed in Q1 and Q2 2026 due to the September 8, 2026 update to the 45ZCF-GREET model. Gross profit for Q3 2026 was $29.5 million, compared to a gross loss of $58 thousand in Q3 2025. Selling, general and administrative expenses increased by $0.1 million to $8.6 million. Operating income improved by $29.4 million to $20.9 million, compared to an operating loss of $8.5 million in Q3 2025. Interest expense increased by $0.8 million to $15.8 million. Net income was $5.2 million, or $0.07 per basic share, compared to a net loss of $23.7 million in Q3 2025. Adjusted EBITDA for Q3 2026 was $24.8 million, compared to negative $5.0 million in Q3 2025, an increase of $29.8 million. Cash at the end of Q3 2026 was $3.4 million, compared to $4.9 million at the end of Q4 2025. Investments in capital projects related to carbon intensity reductions at the Keyes ethanol plant and construction of dairy digesters were $20.2 million for Q3 2026. For the nine months ended September 30, 2026, revenues were $205.5 million, up from $154.3 million in the prior year period, including $37.3 million of Section 45Z tax credit income. Gross profit for the first three quarters was $45.7 million, compared to a gross loss of $8.5 million in the prior year. Selling, general and administrative expenses were $25.5 million, compared to $26.2 million. Operating income was $20.3 million, compared to an operating loss of $34.7 million. Interest expense was $46.9 million, compared to $45.3 million. Net loss for the first three quarters was $25.9 million, improved from a net loss of $71.7 million. Adjusted EBITDA for the first three quarters was $33.2 million, compared to negative $21.5 million, an improvement of $54.7 million. Net cash provided by operating activities was $9.5 million, compared to net cash used of $2.5 million. Investments in capital projects totaled $35.3 million, with $17.1 million for California Ethanol, $17.4 million for Aemetis Biogas, and $0.8 million for other segments. In September 2026, Aemetis received $22.4 million from the sale of Section 45Z production tax credits. In August 2026, Aemetis Biogas amended its Series A Preferred Unit Purchase Agreement to extend the redemption date to December 31, 2026, and reduce the interest rate on the credit agreement to the greater of prime plus 5.0% or 12.0%. The company is pursuing a multi-track financing plan, including preparation for potential long-term financing of the Keyes ethanol plant, ongoing financing for Dairy RNG digester buildout, and progress toward a potential IPO of its India subsidiary, Universal Biofuels Private Limited. The mechanical vapor recompression (MVR) project at Keyes has acquired all necessary equipment and construction is progressing toward completion. As of the end of Q3 2026, Aemetis operates 14 dairy digesters receiving manure feedstock from 17 dairy facilities.

Disagree with this article?

Ctrl + Enter to submit